299 related articles for article (PubMed ID: 30236513)
1. Loss of thioredoxin 2 alters mitochondrial respiratory function and induces cardiomyocyte hypertrophy.
Hu C; Zhang H; Qiao Z; Wang Y; Zhang P; Yang D
Exp Cell Res; 2018 Nov; 372(1):61-72. PubMed ID: 30236513
[TBL] [Abstract][Full Text] [Related]
2. Loss of mitochondrial exo/endonuclease EXOG affects mitochondrial respiration and induces ROS-mediated cardiomyocyte hypertrophy.
Tigchelaar W; Yu H; de Jong AM; van Gilst WH; van der Harst P; Westenbrink BD; de Boer RA; Silljé HH
Am J Physiol Cell Physiol; 2015 Jan; 308(2):C155-63. PubMed ID: 25377088
[TBL] [Abstract][Full Text] [Related]
3. Thioredoxin 2 Offers Protection against Mitochondrial Oxidative Stress in H9c2 Cells and against Myocardial Hypertrophy Induced by Hyperglycemia.
Li H; Xu C; Li Q; Gao X; Sugano E; Tomita H; Yang L; Shi S
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28914755
[TBL] [Abstract][Full Text] [Related]
4. Adiponectin mediates cardioprotection in oxidative stress-induced cardiac myocyte remodeling.
Essick EE; Ouchi N; Wilson RM; Ohashi K; Ghobrial J; Shibata R; Pimentel DR; Sam F
Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H984-93. PubMed ID: 21666115
[TBL] [Abstract][Full Text] [Related]
5. Adenosine monophosphate-activated protein kinase attenuates cardiomyocyte hypertrophy through regulation of FOXO3a/MAFbx signaling pathway.
Chen B; Wu Q; Xiong Z; Ma Y; Yu S; Chen D; Huang S; Dong Y
Acta Biochim Biophys Sin (Shanghai); 2016 Sep; 48(9):827-32. PubMed ID: 27521792
[TBL] [Abstract][Full Text] [Related]
6. Sestrin2-AMPK activation protects mitochondrial function against glucose deprivation-induced cytotoxicity.
Seo K; Ki SH; Shin SM
Cell Signal; 2015 Jul; 27(7):1533-43. PubMed ID: 25778901
[TBL] [Abstract][Full Text] [Related]
7. Targeting Peroxisome Proliferator Activated Receptor α (PPAR α) for the Prevention of Mitochondrial Impairment and Hypertrophy in Cardiomyocytes.
Kar D; Bandyopadhyay A
Cell Physiol Biochem; 2018; 49(1):245-259. PubMed ID: 30138942
[TBL] [Abstract][Full Text] [Related]
8. Activation of AMPK inhibits cardiomyocyte hypertrophy by modulating of the FOXO1/MuRF1 signaling pathway in vitro.
Chen BL; Ma YD; Meng RS; Xiong ZJ; Wang HN; Zeng JY; Liu C; Dong YG
Acta Pharmacol Sin; 2010 Jul; 31(7):798-804. PubMed ID: 20581852
[TBL] [Abstract][Full Text] [Related]
9. An α
Weng X; Liu H; Zhang X; Sun Q; Li C; Gu M; Xu Y; Li S; Li W; Du J
Int J Med Sci; 2020; 17(16):2454-2467. PubMed ID: 33029088
[No Abstract] [Full Text] [Related]
10. Mechanistic Role of Thioredoxin 2 in Heart Failure.
Chen C; Chen H; Zhou HJ; Ji W; Min W
Adv Exp Med Biol; 2017; 982():265-276. PubMed ID: 28551792
[TBL] [Abstract][Full Text] [Related]
11. Iron-induced generation of mitochondrial ROS depends on AMPK activity.
Huang H; Chen J; Lu H; Zhou M; Chai Z; Hu Y
Biometals; 2017 Aug; 30(4):623-628. PubMed ID: 28608291
[TBL] [Abstract][Full Text] [Related]
12. Metabolic switch and hypertrophy of cardiomyocytes following treatment with angiotensin II are prevented by AMP-activated protein kinase.
Stuck BJ; Lenski M; Böhm M; Laufs U
J Biol Chem; 2008 Nov; 283(47):32562-9. PubMed ID: 18790741
[TBL] [Abstract][Full Text] [Related]
13. Differential AMPK phosphorylation sites associated with phenylephrine vs. antihypertrophic effects of adenosine agonists in neonatal rat ventricular myocytes.
Pang T; Rajapurohitam V; Cook MA; Karmazyn M
Am J Physiol Heart Circ Physiol; 2010 May; 298(5):H1382-90. PubMed ID: 20190100
[TBL] [Abstract][Full Text] [Related]
14. Activation of the AMPK-FOXO3 pathway reduces fatty acid-induced increase in intracellular reactive oxygen species by upregulating thioredoxin.
Li XN; Song J; Zhang L; LeMaire SA; Hou X; Zhang C; Coselli JS; Chen L; Wang XL; Zhang Y; Shen YH
Diabetes; 2009 Oct; 58(10):2246-57. PubMed ID: 19592618
[TBL] [Abstract][Full Text] [Related]
15. Thioredoxin-2 inhibits mitochondrial reactive oxygen species generation and apoptosis stress kinase-1 activity to maintain cardiac function.
Huang Q; Zhou HJ; Zhang H; Huang Y; Hinojosa-Kirschenbaum F; Fan P; Yao L; Belardinelli L; Tellides G; Giordano FJ; Budas GR; Min W
Circulation; 2015 Mar; 131(12):1082-97. PubMed ID: 25628390
[TBL] [Abstract][Full Text] [Related]
16. Implications of the mitochondrial interactome of mammalian thioredoxin 2 for normal cellular function and disease.
Chasapis CT; Makridakis M; Damdimopoulos AE; Zoidakis J; Lygirou V; Mavroidis M; Vlahou A; Miranda-Vizuete A; Spyrou G; Vlamis-Gardikas A
Free Radic Biol Med; 2019 Jun; 137():59-73. PubMed ID: 31018154
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia inhibits expression and function of mitochondrial thioredoxin 2 to promote pulmonary hypertension.
Adesina SE; Wade BE; Bijli KM; Kang BY; Williams CR; Ma J; Go YM; Hart CM; Sutliff RL
Am J Physiol Lung Cell Mol Physiol; 2017 May; 312(5):L599-L608. PubMed ID: 28130258
[TBL] [Abstract][Full Text] [Related]
18. TRPC3 deficiency attenuates high salt-induced cardiac hypertrophy by alleviating cardiac mitochondrial dysfunction.
Ma T; Lin S; Wang B; Wang Q; Xia W; Zhang H; Cui Y; He C; Wu H; Sun F; Zhao Z; Gao P; Zhu Z; Liu D
Biochem Biophys Res Commun; 2019 Nov; 519(4):674-681. PubMed ID: 31543348
[TBL] [Abstract][Full Text] [Related]
19. TXNIP mediated the oxidative stress response in glomerular mesangial cells partially through AMPK pathway.
Xu W; Wang L; Li J; Cai Y; Xue Y
Biomed Pharmacother; 2018 Nov; 107():785-792. PubMed ID: 30142540
[TBL] [Abstract][Full Text] [Related]
20. PKD deletion promotes autophagy and inhibits hypertrophy in cardiomyocyte.
Zhao D; Gao Y; Wang W; Pei H; Xu C; Zhao Z
Exp Cell Res; 2020 Jan; 386(2):111742. PubMed ID: 31759056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
